UPDATE 1-U.S. FDA panel backs Aerie's glaucoma drug Rhopressa
October 13, 2017 at 13:32 PM EDT
Oct 13 (Reuters) - Aerie Pharmaceuticals Inc's experimental glaucoma treatment should be approved, an advisory committee to the U.S. Food and Drug Administration said on Friday, after it found the benefits outweigh the risks.
